Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals

Understanding the magnitude of responses to vaccination during the ongoing SARS-CoV-2 pandemic is essential for ultimate mitigation of the disease. Here, we describe a cohort of 102 subjects (70 COVID-19-naïve, 32 COVID-19-experienced) who received two doses of one of the mRNA vaccines (BNT162b2 (Pf...

Descripción completa

Detalles Bibliográficos
Autores principales: Uprichard, Susan L., O’Brien, Amornrat, Evdokimova, Monika, Rowe, Cynthia L., Joyce, Cara, Hackbart, Matthew, Cruz-Pulido, Yazmin E., Cohen, Courtney A., Rock, Michelle L., Dye, John M., Kuehnert, Paul, Ricks, Keersten M., Casper, Marybeth, Linhart, Lori, Anderson, Katrina, Kirk, Laura, Maggiore, Jack A., Herbert, Andrew S., Clark, Nina M., Reid, Gail E., Baker, Susan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878640/
https://www.ncbi.nlm.nih.gov/pubmed/35215962
http://dx.doi.org/10.3390/v14020370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878640/
https://www.ncbi.nlm.nih.gov/pubmed/35215962
http://dx.doi.org/10.3390/v14020370

Ejemplares similares